NEW DELHI/HYDERABAD: Nearly one-third of those who took Covaxin jabs suffered 'adverse events of special interest' within a year of getting vaccinated, claims a study in Drug Safety, an academic
NEW DELHI/HYDERABAD: Nearly one-third of those who took Covaxin jabs suffered 'adverse events of special interest' within a year of getting vaccinated, claims a study in Drug Safety, an academic